Literature DB >> 20005929

Thin-coating as an alternative approach to improve flow properties of ibuprofen powder.

Natalja Genina1, Heikki Räikkönen, Henrik Ehlers, Jyrki Heinämäki, Peep Veski, Jouko Yliruusi.   

Abstract

In the present study, thin-coating as a potential method for improving flow properties of cohesive ibuprofen powder was introduced. Briefly, the technique was based on the successive deposition of ultrasound-assisted fine polymer mist onto the surface of the powdered active pharmaceutical ingredient (API), producing individual particles with a hydrophilic thin-coat. A 0.15% m/V aqueous solution of hydroxypropyl methylcellulose (HPMC) was used. Particle size and surface analysis revealed a decrease in the cohesiveness of ibuprofen powder and an increase in the homogeneity of particle surfaces as a result of polymer treatment. Superficial changes caused a substantial improvement on the flowing characteristics of coated substance over uncoated. The enhancement in flow rate proceeded as the uniformity of the HPMC layer increased. In conclusion, the proposed technique is a simple and effective method that can be used as a continuous process to modify API particle surface properties, which in turn improve the handling of poorly flowable powder. 2009 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20005929     DOI: 10.1016/j.ijpharm.2009.12.005

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  2 in total

1.  Nano-coating of beta-galactosidase onto the surface of lactose by using an ultrasound-assisted technique.

Authors:  Natalja Genina; Heikki Räikkönen; Jyrki Heinämäki; Peep Veski; Jouko Yliruusi
Journal:  AAPS PharmSciTech       Date:  2010-05-29       Impact factor: 3.246

2.  Polymer Nanocoating of Amorphous Drugs for Improving Stability, Dissolution, Powder Flow, and Tabletability: The Case of Chitosan-Coated Indomethacin.

Authors:  Yuhui Li; Junguang Yu; Shenye Hu; Zhenxuan Chen; Mark Sacchetti; Changquan Calvin Sun; Lian Yu
Journal:  Mol Pharm       Date:  2019-02-06       Impact factor: 4.939

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.